EpidemiologyBOYLE, Peter; LANGMAN, J. S.BMJ. British medical journal (International ed.). 2000, Vol 321, Num 7264, pp 805-808, issn 0959-8146Article

Cephalopod biomass and production: An introduction to the symposiumBOYLE, Peter.Bulletin of marine science. 2002, Vol 71, Num 1, pp 13-16, issn 0007-4977, 4 p.Conference Paper

The anti-smoking climate in EU countries and PolandFAGERSTRÖM, Karl; BOYLE, Peter; KUNZE, Michael et al.Lung cancer. 2001, Vol 32, Num 1, pp 1-5, issn 0169-5002Article

Sweetened carbonated beverage consumption and cancer risk: meta-analysis and reviewBOYLE, Peter; KOECHLIN, Alice; AUTIER, Philippe et al.European journal of cancer prevention. 2014, Vol 23, Num 5, pp 481-490, issn 0959-8278, 10 p.Article

Performance and Prediction of Vacuum Combined Surcharge Consolidation at Port of BrisbaneINDRARATNA, Buddhima; RUJIKIATKAMJORN, Cholachat; AMERATUNGA, Jay et al.Journal of geotechnical and geoenvironmental engineering. 2011, Vol 137, Num 11, pp 1009-1018, issn 1090-0241, 10 p.Article

Beyond classical meta-analysis: can inadequately reported studies be included?ROBERTSON, Chris; IDRIS, Nik Ruzni; BOYLE, Peter et al.Drug discovery today. 2004, Vol 9, Num 21, pp 924-931, issn 1359-6446, 8 p.Article

Critical role of prostate biopsy mortality in the number of years of life gained and lost within a prostate cancer screening programmeBONIOL, Mathieu; BOYLE, Peter; AUTIER, Philippe et al.BJU international (Papier). 2012, Vol 110, Num 11, pp 1648-1653, issn 1464-4096, 6 p.Article

Alcohol poisoning is a main determinant of recent mortality trends in Russia : evidence from a detailed analysis of mortality statistics and autopsiesZARIDZE, David; MAXIMOVITCH, Dimitri; LAZAREV, Alexander et al.International journal of epidemiology. 2009, Vol 38, Num 1, pp 143-153, issn 0300-5771, 11 p.Article

Ala394Thr polymorphism in the clock gene NPAS2 : A circadian modifier for the risk of non-Hodgkin's lymphomaYONG ZHU; LEADERER, Derek; TONGZHANG ZHENG et al.International journal of cancer. 2007, Vol 120, Num 2, pp 432-435, issn 0020-7136, 4 p.Article

Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphomaQING LAN; TONGZHANG ZHENG; YEAGER, Meredith et al.Carcinogenesis (New York. Print). 2007, Vol 28, Num 4, pp 823-827, issn 0143-3334, 5 p.Article

Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancerSEVERI, Gianluca; MORRIS, Howard A; MACLNNIS, Robert J et al.Cancer epidemiology, biomarkers & prevention. 2006, Vol 15, Num 6, pp 1137-1141, issn 1055-9965, 5 p.Article

Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960LEVI, Fabio; LUCCHINI, Franca; NEGRI, Eva et al.International journal of cancer. 2004, Vol 110, Num 2, pp 155-169, issn 0020-7136, 15 p.Article

Tobacco and public health : science and policyBOYLE, Peter; GRAY, Nigel; HENNINGFIELD, Jack et al.2004, 798 p., isbn 0-198-52687-3Book

Comparison of a phytotherapeutic agent (Permixon) with an α-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: A 1-year randomized international study. CommentaryDEBRUYNE, Frans; KOCH, Gary; FITZPATRICK, J. M et al.European urology. 2002, Vol 41, Num 5, pp 497-507, issn 0302-2838Article

Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasiaROEHRBORN, Claus G; BOYLE, Peter; NICKEL, J. Curtis et al.Urology (Ridgewood, NJ). 2002, Vol 60, Num 3, pp 434-441, issn 0090-4295Article

Epidemiology of prostate cancerBOYLE, Peter; GANDINI, Sara; BAGLIETTO, Laura et al.European urology. 2001, Vol 39, pp 2-3, issn 0302-2838, SUP4Conference Paper

Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphomaYINGTAI CHEN; TONGZHANG ZHENG; BOYLE, Peter et al.Blood. 2011, Vol 117, Num 2, pp 585-590, issn 0006-4971, 6 p.Article

Genetic Alterations in the PI3K Pathway in Prostate CancerXIUJU SUN; JIAN HUANG; COMMA, Taku et al.Anticancer research. 2009, Vol 29, Num 5, pp 1739-1743, issn 0250-7005, 5 p.Article

The impact of lower urinary tract symptoms and comorbidities on quality of life : the BACH and UREPIK studiesROBERTSON, Chris; LINK, Carol L; MCKINLAY, John B et al.BJU international (Papier). 2007, Vol 99, Num 2, pp 347-354, issn 1464-4096, 8 p.Article

Polymorphisms in DNA repair genes and risk of non-hodgkin lymphoma among women in ConnecticutMIN SHEN; TONGZHANG ZHENG; KANG, Daehee et al.Human genetics. 2006, Vol 119, Num 6, pp 659-668, issn 0340-6717, 10 p.Article

Breast cancerVERONESI, Umberto; BOYLE, Peter; GOLDHIRSCH, Aron et al.Lancet (British edition). 2005, Vol 365, Num 9472, pp 1727-1741, issn 0140-6736, 15 p.Article

Blood transfusion and risk of non-Hodgkin's lymphoma in Connecticut womenYAWEI ZHANG; HOLFORD, Theodore R; TALLINI, Giovanni et al.American journal of epidemiology. 2004, Vol 160, Num 4, pp 325-330, issn 0002-9262, 6 p.Article

Evaluation of the clinical benefit of Permixon and tamsulosin in severe BPH patients-PERMAL study subset analysis. CommentaryDEBRUYNE, Franc; BOYLE, Peter; BROWN, Christian T et al.European urology. 2004, Vol 45, Num 6, pp 773-780, issn 0302-2838, 8 p.Article

Evaluation du bénéfice clinique de Permixon® et de la tamsulosine dans le traitement de l'hypertrophie bénigne de la prostate (HBP) sévère : analyse d'un sous-groupe de l'étude Permal = Evaluation of the clinical benefit of Permixon® and tamsulosin in severe bph patients: PERMAL study subset analysisDEBRUYNE, Frans; BOYLE, Peter; CALAIS DA SILVA, Fernando et al.Progrès en urologie (Paris). 2004, Vol 14, Num 3, pp 326-331, issn 1166-7087, 6 p.Article

Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. CommentaryPASTORINO, Ugo; BELLOMI, Massimo; LANDONI, Claudio et al.Lancet (British edition). 2003, Vol 362, Num 9384, pp 588-589, issn 0140-6736, 7 p.Article